$KYMR news
The latest KYMR stock news: headlines, filings, AI summaries and sentiment for $KYMR, updated around the clock.
- Kymera Therapeutics Reports Q3 2026 Results and Positive Phase I Data for KT-579
- Kymera Therapeutics Reports Q3 GAAP EPS of -$1.32, Missing Estimates
- Kymera Therapeutics, Inc. - 10-Q Filing
- Kymera Therapeutics, Inc. - 8-K Filing
- Shareholder Investigation Announced Against Kymera Therapeutics, Inc.
- North Immunology to go public via reverse merger with Aethlon Medical
- Kymera Therapeutics, Inc. - 8-K Filing
- Shareholder Investigation Announced Against Kymera Therapeutics, Inc.
- Kymera CEO Sells $6 Million in Stock After Significant Share Price Increase
- Kymera CEO Sells $6 Million in Stock After Significant Share Price Increase
- Kymera Therapeutics Announces Early Completion of Phase 2b Trial Enrollment
- Kymera Therapeutics Stock Surges on Early Trial Enrollment Completion
- Stocks Making Significant Moves Midday: BlackBerry Surges, Apple and Microsoft Decline
- Kymera Therapeutics, Inc. - 8-K Filing
- Shareholder Investigation Announced Against Kymera Therapeutics, Inc.
- FDA Grants Fast Track Designation to Kymera Therapeutics' KT-621 for Eosinophilic Asthma